康众医疗：上半年亏损73.94万元 由盈转亏

Core Viewpoint - Kangzhong Medical (688607) reported a revenue of 145 million yuan for the first half of 2025, marking a year-on-year growth of 12.41%. However, the company experienced a net loss attributable to shareholders of 739,400 yuan, a significant decline from a profit of 7.32 million yuan in the same period last year, indicating a shift from profit to loss [1]. Revenue Performance - The revenue growth was primarily driven by the steady advancement in the application and transformation of new products and technologies [1]. - The company has deepened strategic collaborative relationships with core customers and actively expanded overseas market promotion channels [1].